Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.8300
+0.1500 (8.93%)
NASDAQ· Last Trade: Jun 20th, 5:47 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors